The regenerative medicine market was valued at US$ 11.77 billion in 2021 and is projected to reach US$ 37.48 billion by 2028; it is expected to grow at a CAGR of 17.9% from 2022 to 2028.
Regenerative medicine is an innovative field of medicine that develops methods for replacing/regenerating human cells, tissues, or organs to restore normal functions. It can heal tissues or organs by stimulating body’s own repair mechanisms. Regenerative medicine allows scientists to grow tissues and organs in laboratory and safely implant them in the body when it cannot heal itself.
Increasing adoption of gene therapies, stem cell therapies, and tissue engineering; growing number of approvals for cell and gene therapies; and technological advancements in the field of regenerative medicine are the key factors driving the market growth. However, the high cost of these therapies is hampering the market expansion.
Get sample PDF Brochure at: https://www.theinsightpartners.com/sample/TIPHE100001194/
Integra LifeSciences; Gilead Sciences, Inc; Novartis AG; Vericel Corporation; Wright Medical Group N.V.; MiMedx Group; Osiris Therapeutics, Inc.; Stryker Corporation; Spark Therapeutics, Inc.; and Medtronic plc are among the leading companies operating in the global regenerative medicine market.
The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the regenerative medicine market is primarily attributed to increasing adoption of gene therapies, stem cell therapies, and tissue engineering; growing number of approvals for cell and gene therapies; and technological advancements in the field of regenerative medicine. However, the high cost of these therapies is hampering the growth of regenerative medicine market.
The COVID-19 pandemic had a positive impact on the regenerative medicine market growth. Pharmaceutical and biotechnology companies invested a huge amount to develop several new products for the COVID-19 treatment. The demand for the development of new drugs and vaccines increased to tackle the disease. A research study ‘Mesenchymal stem cell treatment for COVID-19’ was conducted at National Clinical Research Center for Infectious Diseases, Beijing, China. Mesenchymal stem cells (MSCs) have anti-inflammatory, immunomodulatory, and regenerative properties.Thus, the safety and effectiveness of MSCs in COVID-19 was investigated in the study. All these aspects indicate the overall positive impact of the pandemic on the regenerative medicine market.
Inquiry Before Buying at: https://www.theinsightpartners.com/inquiry/TIPHE100001194/
Based on application, the regenerative medicine market is divided into musculoskeletal disorders, ocular disorders, oncology, wound care, and diabetes. In 2021, the oncology segment held the largest market share and is expected to grow at the highest CAGR over the forecast period. The increasing prevalence of cancer and growing research activities for its treatment are the major factors driving the segment’s growth. As per the American Cancer Society, in 2021, 1.9 million cancer cases and 608,570 deaths due to same were reported in the US. According to the European Commission, in 2020, 4 million cancer cases were reported in Europe. The disease also caused 1.9 million deaths in the region. The Cancer Atlas report stated that in 2018, 8.2 million cancer cases were reported in Asia Pacific and 5.2 million patients died of the same. Such rising prevalence of cancer across the globe is likely to increase the demand for novel therapeutics.
By region, the global regenerative medicine market is split into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the US is the largest market. Asia Pacific is expected to exhibit the fastest growth due to growing healthcare infrastructure and evolving pharmaceutical and biopharmaceutical industries. Moreover, the increasing involvement of contract research organizations (CROs) in the development and production of novel therapies is expected to influence the overall growth of the market during the forecast period.
By geography, the global market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Place an Order Copy of This Report (Single User License) at: https://www.theinsightpartners.com/buy/TIPHE100001194/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876